Eli Lilly had agreed to cap the price of insulin at $35 per month for 4 years and provide a $13.5 million cash fund, however, a dozen state attorneys general, some with their own insulin lawsuits, had objected to the settlement.

The proliferation of advertising on social media for Ozempic, Wegovy and other weight loss drugs will be a key part of the upcoming "stomach paralysis" lawsuits against Novo Nordisk and Eli Lilly.

Following opioid settlements announced by CVS, Walgreens and Walmart, the retailer announced the settlement, after a number of lawsuits claimed the grocery chain helped fuel the opioid epidemic.

U.S. District Judge Dan Polster, on Wednesday, ordered the three pharmacies to provide abatement funds to two Ohio counties who won a Nov. 23 verdict over the opioid crisis.

Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.

The settlement comes after the state's Supreme Court reversed a $465M judgment the state obtained against Johnson & Johnson's Janssen Pharmaceuticals.

Walgreens is the final defendant to settle in Florida's opioid case, bringing the state's total litigation wins to more than $3 billion.

San Francisco's opioid trial began this week, with drug companies insisting that Purdue Pharma should shoulder the blame for the crisis.